BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30779458)

  • 1. Intraoperative electron beam radiotherapy for locoregionally persistent or recurrent head and neck cancer.
    Wald P; Grecula J; Walston S; Wei L; Bhatt A; Martin D; Bonomi M; Rocco J; Old M; Teknos T; Blakaj D
    Head Neck; 2019 Jul; 41(7):2148-2153. PubMed ID: 30779458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
    Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
    Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraoperative electron beam radiotherapy for previously irradiated advanced head and neck malignancies.
    Nag S; Schuller DE; Martinez-Monge R; Rodriguez-Villalba S; Grecula J; Bauer C
    Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1085-9. PubMed ID: 9869233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative radiation therapy for recurrent head-and-neck cancer: the UCSF experience.
    Chen AM; Bucci MK; Singer MI; Garcia J; Kaplan MJ; Chan AS; Phillips TL
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):122-9. PubMed ID: 17084543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy.
    Sun L; Chin RI; Gastman B; Thorstad W; Yom SS; Reddy CA; Nussenbaum B; Wang SJ; Knackstedt T; Vidimos AT; Koyfman SA; Manyam BV
    JAMA Dermatol; 2019 Apr; 155(4):442-447. PubMed ID: 30810715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience.
    Ling SM; Roach M; Fu KK; Coleman C; Chan A; Singer M
    Cancer J Sci Am; 1996; 2(6):321-9. PubMed ID: 9166552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose-rate intraoperative radiation therapy for recurrent head-and-neck cancer.
    Perry DJ; Chan K; Wolden S; Zelefsky MJ; Chiu J; Cohen G; Zaider M; Kraus D; Shah J; Lee N
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1140-6. PubMed ID: 19560882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative radiation therapy for the treatment of recurrent retroperitoneal and pelvic tumors: a single-institution analysis.
    Coelho TM; Fogaroli RC; Pellizzon ACA; De Castro DG; Gondim GRM; Silva MLG; Chen MJ; Ramos H
    Radiat Oncol; 2018 Nov; 13(1):224. PubMed ID: 30454036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of external beam radiation therapy in patients treated with and without extended surgery and intraoperative electrons for locally recurrent rectal cancer: 16-year experience in a single institution.
    Calvo FA; Sole CV; Alvarez de Sierra P; Gómez-Espí M; Blanco J; Lozano MA; Del Valle E; Rodriguez M; Muñoz-Calero A; Turégano F; Herranz R; Gonzalez-Bayon L; García-Sabrido JL
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):892-900. PubMed ID: 23845842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage surgery and radiotherapy including intraoperative electron radiotherapy in isolated locally recurrent tumors: Predictors of outcome.
    Cambeiro M; Calvo FA; Aristu JJ; Jimenez MM; San-Julian M; Alcalde J; Hernandez-Lizoain JL; Jurado M; Martínez-Monge R
    Radiother Oncol; 2015 Aug; 116(2):316-22. PubMed ID: 26232130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative electron beam radiotherapy and perioperative high-dose-rate brachytherapy in previously irradiated oligorecurrent gynecological cancer: clinical outcome analysis.
    Jablonska PA; Cambeiro M; Gimeno M; Aramendía JM; Mínguez JA; Alcázar JL; Aristu JJ; Calvo FA; Martínez-Monge R
    Clin Transl Oncol; 2021 Sep; 23(9):1934-1941. PubMed ID: 33835408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodality therapy including salvage surgical resection and intraoperative radiotherapy for patients with squamous-cell carcinoma of the anus with residual or recurrent disease after primary chemoradiotherapy.
    Hallemeier CL; You YN; Larson DW; Dozois EJ; Nelson H; Klein KA; Miller RC; Haddock MG
    Dis Colon Rectum; 2014 Apr; 57(4):442-8. PubMed ID: 24608300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of complications and outcome in high-risk squamous cell head-and-neck cancer treated with perioperative high-dose rate brachytherapy (PHDRB).
    Martínez-Monge R; Pagola Divassón M; Cambeiro M; Gaztañaga M; Moreno M; Arbea L; Montesdeoca N; Alcalde J
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e245-54. PubMed ID: 21620582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma.
    Fayette J; Molin Y; Lavergne E; Montbarbon X; Racadot S; Poupart M; Ramade A; Zrounba P; Ceruse P; Pommier P
    Drug Des Devel Ther; 2015; 9():6203-10. PubMed ID: 26648696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative electron beam radiotherapy and extended surgical resection for gynecological pelvic recurrent malignancies with and without external beam radiation therapy: long-term outcomes.
    Calvo FA; Sole CV; Lozano MA; Gonzalez-Bayon L; Gonzalez-Sansegundo C; Alvarez A; Blanco J; Calín A; Lizarraga S; García-Sabrido JL
    Gynecol Oncol; 2013 Sep; 130(3):537-44. PubMed ID: 23707668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative radiotherapy as an immediate adjuvant treatment of rectal cancer due to limited access to external-beam radiotherapy.
    Potemin S; Kübler J; Uvarov I; Wenz F; Giordano F
    Radiat Oncol; 2020 Jan; 15(1):11. PubMed ID: 31924250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
    Argiris A; Stenson KM; Brockstein BE; Mittal BB; Pelzer H; Kies MS; Jayaram P; Portugal L; Wenig BL; Rosen FR; Haraf DJ; Vokes EE
    Head Neck; 2004 May; 26(5):447-55. PubMed ID: 15122662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer.
    Rühle A; Sprave T; Kalckreuth T; Stoian R; Haehl E; Zamboglou C; Laszig R; Knopf A; Grosu AL; Nicolay NH
    Radiat Oncol; 2020 Apr; 15(1):81. PubMed ID: 32299456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer.
    Seiwert TY; Melotek JM; Blair EA; Stenson KM; Salama JK; Witt ME; Brisson RJ; Chawla A; Dekker A; Lingen MW; Kocherginsky M; Villaflor VM; Cohen EE; Haraf DJ; Vokes EE
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):21-9. PubMed ID: 27511844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of adjuvant radiation or re-excision for early stage vulvar squamous cell carcinoma with positive or close surgical margins.
    Bedell SM; Hedberg C; Griffin A; Pearson H; Wilhite A; Rubin N; Erickson BK
    Gynecol Oncol; 2019 Aug; 154(2):276-279. PubMed ID: 31171409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.